Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners.

Leukemia·2026
Same author

Recent advances in AML with mutated NPM1.

International journal of hematology·2024
Same author

Initiating-clone analysis in patients with acute myeloid leukemia secondary to essential thrombocythemia.

Scientific reports·2024
Same author

Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.

Nature communications·2022
Same author

Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Blood advances·2021
Same author

Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.

PloS one·2018

相关实验视频

Updated: Jun 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

37

最近在AML的进展与复发性遗传异常.

Yuichi Ishikawa1

  • 1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-ku, Nagoya, 466-8550, Japan. yishikaw@med.nagoya-u.ac.jp.

International journal of hematology
|October 1, 2024
PubMed
概括
此摘要是机器生成的。

有有利风险的急性髓性白血病 (AML) 需要更好的风险分层,因为复发. 研究探讨分子异常和FLT3突变,以改善AML患者的治疗策略.

关键词:
在FLT3突变中.在AML,AML就是AML.有利的风险有利的风险.分子向疗法分子向疗法经常出现的遗传异常.

更多相关视频

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K

相关实验视频

Last Updated: Jun 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

37
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
09:49

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

9.5K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 分子生物学分子生物学

背景情况:

  • 急性髓性白血病 (AML) 是一种复杂的疾病,具有影响患者结果的多种分子特征.
  • 目前AML的预后模型依赖于染色体和遗传异常,但挑战仍然存在,特别是在有利的风险群体.
  • 具有有利风险的AML,包括NPM1或CEBPA突变的病例,在很大一部分患者中仍然出现复发.

研究的目的:

  • 解决改善有利风险AML风险分层的需要.
  • 调查分子异常,包括FLT3突变在AML病变和预后中的作用.
  • 讨论AML针对性治疗的当前趋势和挑战.

主要方法:

  • 关于AML分子异常的当前文献的综述.
  • 对NPM1,CEBPA和FLT3.3等遗传突变的预后影响的分析.
  • 讨论针对性治疗的发展和AML的耐药性机制.

主要成果:

  • 在细胞遗传学上正常的AML中,NPM1和CEBPA突变定义了一个有利的风险组,但在40%的患者中发生复发.
  • 在有利风险的AML亚型中,FLT3突变很常见,但它们的预后意义仍在争论中.
  • 向疗法已经成为有效的治疗方法,但耐药性构成了重大挑战.

结论:

  • 基于分子形状的进一步风险分层对于优化有利风险AML的治疗至关重要.
  • 了解分子异常和开发新的向疗法是改善AML患者治疗结果的关键.
  • 解决针对性治疗的耐药性对于AML的长期治疗成功至关重要.